Formula C21H22FN3O | Molar mass 351.42 g/mol | |
 | ||
LY-334370 is a selective 5-HT1F receptor agonist which was under development by Eli Lilly and Company for the treatment of migraine headaches. The drug showed efficacy in a phase II clinical trial but further development was halted due to toxicity detected in animals.
References
LY-334370 Wikipedia(Text) CC BY-SA